Surgical resection of lung metastases: results from 529 patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/18052 |
Resumo: | OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy. METHODS: A retrospective review was performed of patients who were admitted with lung metastases, and who underwent thoracotomy for resection, after treatment of a primary tumor. Data were collected regarding demographics, tumor features, treatment, and outcome. RESULTS: Patients (n = 529) were submitted to a total of 776 thoracotomies. Median follow-up time across all patients was 21.6 months (range: 0-192 months). The postoperative complication rate was 9.3%, and the 30-day mortality rate was 0.2%. The ninety-month overall survival rate for all patients was 30.4%. Multivariate analysis identified the number of pulmonary nodules detected on preoperative CT-scan, the number of malignant nodules resected, and complete resection as the independent prognostic factors for overall survival. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after resection. |
id |
USP-19_8c254f1a3f4e7d61bac75146b214ed78 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/18052 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Surgical resection of lung metastases: results from 529 patients LungMetastasesResectionMetastasectomyPrognostic factors OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy. METHODS: A retrospective review was performed of patients who were admitted with lung metastases, and who underwent thoracotomy for resection, after treatment of a primary tumor. Data were collected regarding demographics, tumor features, treatment, and outcome. RESULTS: Patients (n = 529) were submitted to a total of 776 thoracotomies. Median follow-up time across all patients was 21.6 months (range: 0-192 months). The postoperative complication rate was 9.3%, and the 30-day mortality rate was 0.2%. The ninety-month overall survival rate for all patients was 30.4%. Multivariate analysis identified the number of pulmonary nodules detected on preoperative CT-scan, the number of malignant nodules resected, and complete resection as the independent prognostic factors for overall survival. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after resection. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2009-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1805210.1590/S1807-59322009000600008Clinics; Vol. 64 No. 6 (2009); 535-541 Clinics; v. 64 n. 6 (2009); 535-541 Clinics; Vol. 64 Núm. 6 (2009); 535-541 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/18052/20117Younes, Riad N.Gross, Jefferson L.Taira, Andrea M.Martins, Andrea Aparecida C.Neves, Giuliana Sigoloinfo:eu-repo/semantics/openAccess2012-05-22T18:53:22Zoai:revistas.usp.br:article/18052Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-22T18:53:22Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Surgical resection of lung metastases: results from 529 patients |
title |
Surgical resection of lung metastases: results from 529 patients |
spellingShingle |
Surgical resection of lung metastases: results from 529 patients Younes, Riad N. Lung Metastases Resection Metastasectomy Prognostic factors |
title_short |
Surgical resection of lung metastases: results from 529 patients |
title_full |
Surgical resection of lung metastases: results from 529 patients |
title_fullStr |
Surgical resection of lung metastases: results from 529 patients |
title_full_unstemmed |
Surgical resection of lung metastases: results from 529 patients |
title_sort |
Surgical resection of lung metastases: results from 529 patients |
author |
Younes, Riad N. |
author_facet |
Younes, Riad N. Gross, Jefferson L. Taira, Andrea M. Martins, Andrea Aparecida C. Neves, Giuliana Sigolo |
author_role |
author |
author2 |
Gross, Jefferson L. Taira, Andrea M. Martins, Andrea Aparecida C. Neves, Giuliana Sigolo |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Younes, Riad N. Gross, Jefferson L. Taira, Andrea M. Martins, Andrea Aparecida C. Neves, Giuliana Sigolo |
dc.subject.por.fl_str_mv |
Lung Metastases Resection Metastasectomy Prognostic factors |
topic |
Lung Metastases Resection Metastasectomy Prognostic factors |
description |
OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy. METHODS: A retrospective review was performed of patients who were admitted with lung metastases, and who underwent thoracotomy for resection, after treatment of a primary tumor. Data were collected regarding demographics, tumor features, treatment, and outcome. RESULTS: Patients (n = 529) were submitted to a total of 776 thoracotomies. Median follow-up time across all patients was 21.6 months (range: 0-192 months). The postoperative complication rate was 9.3%, and the 30-day mortality rate was 0.2%. The ninety-month overall survival rate for all patients was 30.4%. Multivariate analysis identified the number of pulmonary nodules detected on preoperative CT-scan, the number of malignant nodules resected, and complete resection as the independent prognostic factors for overall survival. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after resection. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/18052 10.1590/S1807-59322009000600008 |
url |
https://www.revistas.usp.br/clinics/article/view/18052 |
identifier_str_mv |
10.1590/S1807-59322009000600008 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/18052/20117 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 64 No. 6 (2009); 535-541 Clinics; v. 64 n. 6 (2009); 535-541 Clinics; Vol. 64 Núm. 6 (2009); 535-541 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222754776023040 |